SCHOTT Pharma And KORU Medical Systems Announce Collaboration To Advance Large Volume Subcutaneous Infusion
Portfolio Pulse from Benzinga Newsdesk
SCHOTT Pharma and KORU Medical Systems (NASDAQ:KRMD) have announced a collaboration to advance large volume subcutaneous infusion. The partnership aims to optimize drug delivery using KORU Medical's Freedom Infusion System and SCHOTT Pharma's prefillable polymer syringes, potentially simplifying and de-risking the administration of large volume subcutaneous therapies.
June 05, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
KORU Medical Systems (NASDAQ:KRMD) has partnered with SCHOTT Pharma to optimize large volume subcutaneous drug delivery. This collaboration could enhance the company's product offerings and market position in the medical technology sector.
The collaboration with SCHOTT Pharma is likely to enhance KORU Medical's product offerings and streamline the drug development process, which could positively impact the company's market position and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100